The methodology behind the analysis reflects the modern standards of evidence synthesis. The research team searched MEDLINE through PubMed, Embase, Scopus, and Web of Science from database inception to July 2026, casting a wide net for observational studies that evaluated laboratory-confirmed enteric infections against stunting outcomes in children. Nineteen studies passed the quality threshold for the qualitative synthesis, and fourteen contributed effect estimates to the quantitative meta-analysis. The authors followed the PRISMA 2020 reporting guidelines, pooled odds ratios using random-effects models, and assessed risk of bias with the Newcastle–Ottawa Scale. Certainty of evidence was judged using the GRADE framework, the same structured approach that underpins World Health Organization guideline development. This combination of transparent searching, formal bias assessment, and pre-specified subgroup analyses gives the review a methodological rigor that many entries in the stunting literature have lacked.

The headline number deserves unpacking. An odds ratio of 1.94 means that children with laboratory-confirmed enteric infections had roughly 94 percent higher odds of being stunted, defined as height-for-age more than two standard deviations below the reference median, compared with children without such infections. That is a substantial association in a field where effect estimates often hover close to unity. But the pooled figure came with an I-squared statistic of 85.6 percent, indicating that more than eight-tenths of the variability among studies reflected real differences between populations and methods rather than random noise. In practical terms, the pooled odds ratio describes an average of a highly heterogeneous body of evidence, and the authors were careful not to oversell it. Heterogeneity of this magnitude is common in observational meta-analyses of infection and nutrition, where study settings range from urban slums to rural highlands and diagnostic tools range from microscopy to multiplex PCR.

To probe that heterogeneity, the team conducted pre-specified subgroup analyses across pathogen domains: bacterial, viral, protozoal, helminthic, and non-specific parasitic infections. The most consequential finding of the review may be what did not emerge. Despite wide differences in the biology of these organisms, the associations with stunting were broadly comparable across domains, with no statistically significant differences between pathogen groups. Bacteria such as enteroaggregative Escherichia coli, viruses such as rotavirus, protozoa such as Giardia and Cryptosporidium, and soil-transmitted helminths all appeared to leave children at similar elevated risk of growth faltering. The authors interpret this convergent pattern as evidence that multiple enteric pathogens may impair child growth through shared biological pathways rather than through pathogen-specific mechanisms.

That interpretation aligns with two decades of research into environmental enteric dysfunction, a subclinical condition of the small intestine that has become a central hypothesis in child growth biology. Repeated exposure to fecal pathogens is thought to provoke chronic mucosal inflammation, villous atrophy, increased intestinal permeability, and malabsorption, collectively blunting the child’s ability to convert food into linear growth. Studies cited in the review, including the Environmental Enteric Dysfunction Biopsy Initiative and work linking the condition to carnitine deficiency and altered fatty acid oxidation, describe a gut that is chronically inflamed and metabolically compromised even in children who never present with overt diarrhea. Chronic inflammation also suppresses the growth hormone–insulin-like growth factor-1 axis, the endocrine engine of linear growth, providing a plausible mechanistic bridge from a fecal-contaminated environment to a stunted child.

Meta-regression added a second layer of insight by identifying participant age and adjustment status as significant sources of between-study heterogeneity. The association between enteric infection and stunting was strongest among children younger than two years, which the authors read as a signal about the first 1000 days of life, the window from conception through roughly the second birthday during which linear growth velocity is highest and the developing gut and immune system are most vulnerable to disruption. This timing matters for intervention design. A child whose gut is repeatedly infected during the period of most rapid growth may sustain deficits that nutritional supplementation later in childhood cannot fully reverse, echoing longitudinal findings from the MAL-ED birth cohort across eight low- and middle-income country sites, which documented that even asymptomatic enteropathogen infections measurably depressed linear growth.

The finding that statistical adjustment for confounders shaped the observed effect estimates is equally important for readers interpreting the evidence. Observational studies of infection and stunting must contend with a dense thicket of confounding: household wealth, maternal education, water and sanitation access, breastfeeding practices, and diet all influence both infection risk and growth. Studies that adjusted more comprehensively for these factors produced different effect estimates than those that did not, and the meta-regression captured this as a source of heterogeneity. The very low GRADE rating applied to the pooled evidence reflects these inherent limitations. Association is not causation, reverse causality remains possible, since malnourished children may be more susceptible to infection as well as more harmed by it, and the Review authors are explicit that their pooled estimate should guide hypothesis formation and intervention priority-setting rather than be read as a precise causal coefficient.

The geographical scope of the underlying studies, spanning Ethiopia, Bangladesh, Indonesia, Peru, Zambia, Madagascar, the Philippines, Zimbabwe, and other low- and middle-income settings, underscores that the stunting–infection relationship is concentrated where sanitation infrastructure is weakest. Several included studies examined the interaction between enteric infections and environmental enteric dysfunction directly, and others evaluated how water, sanitation, and hygiene interventions perform in children carrying different pathogen burdens. Collectively, this literature suggests that the classic nutrition-centric framing of stunting, in which food insecurity is treated as the dominant driver, captures only part of the story. A child can consume adequate calories and still fail to grow if a chronically inflamed gut cannot absorb them.

For policymakers, the practical implications of the review are captured in its stated impact summary: the findings support integrating infection prevention, sanitation, and nutritional interventions into child stunting reduction programs, rather than pursuing these strategies in silos. That means pairing supplementary feeding and dietary diversification with safe water, improved sanitation, deworming where helminth burden is high, and, where available, vaccination against enteric pathogens. The absence of differences between pathogen domains complicates any pathogen-by-pathogen targeting strategy and instead argues for broad environmental measures that reduce exposure to the fecal–oral pathway as a whole. The vulnerability of children under two further suggests that interventions should begin in pregnancy and infancy, when the marginal return on preventing gut disruption is highest.

The review, published on 26 September 2026 with the DOI 10.1038/s41390-026-05520-4, arrives at a moment when the global health community is assessing why stunting prevalence has declined more slowly than under-five mortality. By quantifying a roughly twofold elevation in stunting odds associated with enteric infections across bacterial, viral, protozoal, and helminthic domains, and by flagging the first 1000 days as the period of maximal vulnerability, it offers both a synthesis of a fragmented literature and a clear agenda for what must come next: longitudinal studies with molecular diagnostics, better confounder control, and intervention trials that test whether breaking the infection–inflammation cycle unlocks growth that nutrition alone cannot deliver. The evidence may be graded very low in certainty, but the direction of the signal, and the scale of the population at risk, give it a weight that few will ignore.

Subject of Research: The association between enteric infections across four pathogen domains and childhood stunting in low- and middle-income countries

Article Title: Enteric infections and childhood stunting: a systematic review and meta-analysis across four pathogen domains

Article References: Pauzi, R. Y., Iqhrammullah, M., Ihtiaringtyas, S., Ilmi, A. N., Kumaratih, L. W., Yuliana, P. T., Aqila, R. A., & Raizma, E. Z. N. (2026). Enteric infections and childhood stunting: a systematic review and meta-analysis across four pathogen domains. Pediatric Research. https://doi.org/10.1038/s41390-026-05520-4

Image Credits: AI Generated

DOI: 10.1038/s41390-026-05520-4

Keywords: childhood stunting, enteric infections, meta-analysis, systematic review, environmental enteric dysfunction, gut microbiology, pediatric growth, first 1000 days, soil-transmitted helminths, water sanitation and hygiene, low- and middle-income countries, GRADE evidence

The study rests on a simple but powerful epidemiological premise: antibodies of the immunoglobulin G class persist for years after infection or vaccination, so their prevalence in a population acts as a cumulative record of exposure. Because hepatitis A and hepatitis E are both transmitted primarily through the faecal-oral route, their seroprevalence patterns are tightly coupled to sanitation, water quality, hygiene practices and socio-economic conditions. When a community improves its water and sanitation infrastructure, the age at which children first encounter these viruses tends to rise, shifting the burden of susceptibility toward older individuals in whom infection is more likely to cause symptomatic disease. This phenomenon, known as epidemiological transition, is one of the central concerns for vaccination policy in low- and middle-income countries undergoing rapid urban development.

To test whether such a transition was underway in Vellore, the team drew on biobanked serum samples from 600 participants in the 2013 survey and 558 participants in the 2022 survey, all aged between one and forty years. Each sample was tested for IgG antibodies specific to hepatitis A virus and hepatitis E virus. The investigators then stratified seroprevalence estimates by age, gender and residential cluster, allowing them to detect not only overall changes between the two survey years but also geographic heterogeneity within the city. Statistical comparisons of seropositivity between years were carried out using proportion tests or Fisher’s exact tests, depending on the structure of the data.

The hepatitis A results were striking in their consistency. Seroprevalence exceeded 80 percent among children aged one to five years in both surveys and climbed to 100 percent among individuals aged sixteen and above, in 2013 as well as 2022. No statistically significant differences in hepatitis A seroprevalence were observed between the two survey years in any age stratum. In practical terms, nearly every resident of urban Vellore had been infected with hepatitis A virus by early adulthood in both eras, and infection continued to occur early in childhood. The virus, in this setting, remains firmly endemic, and the population’s collective immunity remains high.

Hepatitis E told a different story. IgG seroprevalence against this virus was low among children and adolescents in both surveys and increased progressively with age, a pattern consistent with sporadic rather than sustained childhood transmission. Among adults aged twenty-six to forty years, seroprevalence rose from 18 percent in 2013, with a 95 percent confidence interval of 12 to 27 percent, to 24 percent in 2022, with a 95 percent confidence interval of 16 to 32 percent. Although this increase suggests a possible gradual accumulation of exposure in adulthood, the change did not reach statistical significance, and the authors are careful not to overinterpret it. Across both viruses, no significant gender-based differences in seropositivity were detected.

Cluster-wise analysis added a spatial dimension to these findings. Hepatitis A seroprevalence was uniformly high across all residential clusters sampled in Vellore, reflecting the pervasive nature of early-life exposure to the virus throughout the urban environment. Hepatitis E seroprevalence, by contrast, was both low and heterogeneous across clusters, indicating that exposure to this virus is patchy and likely driven by localised factors such as intermittent contamination of water supplies, sanitation gaps in specific neighbourhoods, or differences in food handling practices. This heterogeneity matters for surveillance design, because a citywide average can easily mask pockets of elevated risk where outbreaks of hepatitis E, which can be particularly dangerous for pregnant women, may originate.

Beyond simple prevalence counts, the study employed more sophisticated quantitative tools to probe hepatitis A transmission dynamics. The researchers applied contact matrix and mixture modelling to the serological data to estimate the effective reproduction number, Re, for hepatitis A in each survey year. Mixture modelling, which treats the antibody distribution in a population as a blend of distributions from susceptible and immune individuals, allows researchers to infer the force of infection even from cross-sectional snapshots. The analysis yielded an Re below 1 in both serosurveys, indicating that secondary transmission of hepatitis A was not sustaining epidemic growth in either era, despite the accumulation of susceptible individuals in older age groups over time. This finding suggests that while the age profile of susceptibility may be shifting slowly, the underlying transmission intensity has not yet crossed the threshold that would fuel outbreaks among older, more vulnerable populations.

The implications for vaccination policy are significant. In many middle-income countries that have improved sanitation, hepatitis A has transitioned from a disease of early childhood, where infection is usually asymptomatic, to one affecting older children and adults, in whom clinical illness and occasional severe outcomes are more common. This shift is the classic argument for universal childhood hepatitis A vaccination: immunising children early both protects them and reduces circulation, indirectly shielding older susceptible individuals. The Vellore data show that this transition, while anticipated, has not yet materialised in measurable form; immunity remains high and acquired early, and the effective reproduction number remains below one. The authors note that their findings should inform age-specific considerations for hepatitis A vaccination policy in urban India as it undergoes transition, implying that the window for deciding on vaccination strategy remains open but should be monitored with continued serosurveillance.

For hepatitis E, the picture is one of limited but persistent and age-dependent exposure. The low seroprevalence among the young means that a large fraction of the population reaches adulthood without prior immunity, and the gradual rise in seropositivity with age reflects cumulative adult exposure. The authors highlight the need for targeted hepatitis E surveillance, particularly because the virus causes substantial morbidity in pregnant women and can trigger large outbreaks when water supplies are compromised. The modest, non-significant rise in adult seroprevalence between 2013 and 2022 is consistent with continued low-level transmission that could accelerate under adverse conditions, making sustained monitoring essential.

Perhaps the clearest message of the study is a reaffirmation of the value of water, sanitation and hygiene interventions. The stability of hepatitis A immunity over the decade, and the continued containment of hepatitis E transmission below epidemic thresholds, support continued investment in WASH infrastructure as the backbone of enteric virus control in urban India. At the same time, the study demonstrates the power of repeated, geographically stratified serosurveys using biobanked samples to detect epidemiological change before it becomes clinically visible. As Indian cities continue to grow and modernise, the balance between endemic early-childhood infection and emerging adult susceptibility will determine whether hepatitis A vaccination becomes a public health priority, and whether hepatitis E remains a smouldering, localised threat or flares into wider outbreaks. The Vellore data provide a rigorous baseline against which that future can be measured.

Subject of Research: Decadal changes in IgG seroprevalence of hepatitis A and E virus in urban Vellore, India

Article Title: Decadal changes in IgG seroprevalence of hepatitis A and E virus in Urban Vellore, India: Persistent Endemicity or Epidemiological Shift?

Article References: Decadal changes in IgG seroprevalence of hepatitis A and E virus in Urban Vellore, India: Persistent Endemicity or Epidemiological Shift?. (n.d.). https://doi.org/10.1186/s12879-026-14413-0

Image Credits: AI Generated

DOI: 10.1186/s12879-026-14413-0

Keywords: Hepatitis A, Hepatitis E, IgG seroprevalence, serosurvey, enteric infections, WASH, epidemiological transition, urban India, effective reproduction number, vaccination policy, Decadal, changes